A detailed history of Wilkins Investment Counsel Inc transactions in Amgen Inc stock. As of the latest transaction made, Wilkins Investment Counsel Inc holds 751 shares of AMGN stock, worth $208,973. This represents 0.03% of its overall portfolio holdings.

Number of Shares
751
Previous 751 -0.0%
Holding current value
$208,973
Previous $234,000 2.99%
% of portfolio
0.03%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $201,921 - $243,744
751 New
751 $213,000
Q1 2022

May 10, 2022

SELL
$219.27 - $242.57 $394,686 - $436,626
-1,800 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$221.91 - $258.6 $377,247 - $439,620
-1,700 Reduced 48.57%
1,800 $448,000
Q1 2020

May 11, 2020

SELL
$182.24 - $241.7 $91,120 - $120,850
-500 Reduced 12.5%
3,500 $710,000
Q4 2017

Feb 09, 2018

SELL
$168.79 - $188.59 $46,417 - $51,862
-275 Reduced 6.43%
4,000 $696,000
Q2 2017

Aug 10, 2017

BUY
N/A
4,275
4,275 $736,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wilkins Investment Counsel Inc Portfolio

Follow Wilkins Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilkins Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wilkins Investment Counsel Inc with notifications on news.